Invesco Ltd. (IVZ) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
IVZ Revenue Growth
Revenue Breakdown (FY 2025)
IVZ's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
IVZ Revenue Analysis (2014–2025)
As of May 6, 2026, Invesco Ltd. (IVZ) generated trailing twelve-month (TTM) revenue of $6.59 billion, reflecting strong growth of +14.1% year-over-year. The most recent quarter (Q1 2026) recorded $1.74 billion in revenue, up 3.1% sequentially.
Looking at the longer-term picture, IVZ's 5-year compound annual growth rate (CAGR) stands at +0.7%, indicating moderate growth over time. The company achieved its highest annual revenue of $6.89 billion in 2021.
Revenue diversification analysis shows IVZ's business is primarily driven by Investment Advice (72%), Distribution and Shareholder Service (24%), and Financial Service, Other (3%). With over half of revenue concentrated in Investment Advice, the company maintains significant focus in this area while developing other growth vectors.
When compared to Financial Services sector peers including BEN, TROW, and AMG. Compare IVZ vs BEN →
IVZ Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| IVZCurrent | $6.6B | +14.1% | +0.7% | -10.9% | |
 BEN | $8.8B | - | - | 6.9% | |
 TROW | $7.3B | - | - | 29.9% | |
 AMG | $2.4B | - | - | 31.8% | |
 VRTS | $831M | - | - | 17.4% | |
 DHIL | $158M | - | - | 38.4% |
IVZ Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $6.38B | - | $2.75B | 43.2% | $-695,700,000 | -10.9% |
| 2024 | $6.07B | - | $2.03B | 33.4% | $832.1M | 13.7% |
| 2023 | $5.72B | - | $2.01B | 35.1% | $-434,800,000 | -7.6% |
| 2022 | $6.05B | - | $2.44B | 40.3% | $1.32B | 21.8% |
| 2021 | $6.89B | - | $2.83B | 41.1% | $1.79B | 25.9% |
| 2020 | $6.15B | - | $2.39B | 38.9% | $920.4M | 15.0% |
| 2019 | $6.12B | - | $2.52B | 41.1% | $808.2M | 13.2% |
| 2018 | $5.31B | - | $2.21B | 41.6% | $1.20B | 22.7% |
| 2017 | $5.16B | - | $2.17B | 42.1% | $1.28B | 24.8% |
| 2016 | $4.73B | - | $1.96B | 41.4% | $1.15B | 24.3% |
Full IVZ Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See IVZ's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs IVZ Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare IVZ vs BRK-A
Side-by-side business, growth, and profitability comparison vs Berkshire Hathaway Inc..
Start ComparisonIVZ — Frequently Asked Questions
Quick answers to the most common questions about buying IVZ stock.
Is IVZ's revenue growth accelerating or slowing?
IVZ maintains +14.1% revenue growth, in line with its 5-year CAGR of +0.7%. TTM revenue stands at $6.6B. Growth rate remains consistent with historical average.
What is IVZ's long-term revenue growth rate?
Invesco Ltd.'s 5-year revenue CAGR of +0.7% reflects the sustained expansion pattern. Current YoY growth of +14.1% is near this long-term average.
How is IVZ's revenue distributed by segment?
IVZ reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.